Ongoing Research. Expanding Evidence.
Scientific and clinical research on vibroacoustic therapy continues to evolve across neurological, rehabilitative, pain-management, and wellness settings. LifeTone Studio regularly curates and translates emerging research into accessible Evidence Spotlights to help clients, caregivers, and organizations better understand the growing body of evidence.
Evidence Spotlight: Vibroacoustic Therapy / Somatosensory Music Therapy & Depression
A 2024 clinical intervention study investigating whether somatosensory music therapy—a vibroacoustic-based therapeutic modality—could significantly reduce depressive symptoms, improve emotional regulation, lower perceived stress, and restore autonomic nervous system balance in adults diagnosed with depressive disorders.
Evidence Spotlight: Vibroacoustic Stimulation & Athletic Recovery
A peer-reviewed clinical study investigating whether vibroacoustic stimulation could enhance physiological recovery, improve parasympathetic nervous system activation, and accelerate post-exercise recovery in competitive athletes following intense physical exertion.
Evidence Spotlight: Vibroacoustic Therapy (40 Hz) & Fibromyalgia
A clinical study investigating whether 40Hz low-frequency sound stimulation (LFSS), a form of Vibroacoustic Therapy, could significantly reduce fibromyalgia symptoms, improve sleep, reduce pain, enhance function, and improve quality of life in women diagnosed with fibromyalgia.
Evidence Spotlight: Vibroacoustic Therapy (40 Hz) & Alzheimer’s Disease
A 3-year longitudinal clinical case study investigating whether 40Hz gamma-frequency Vibroacoustic Therapy (Rhythmic Sensory Stimulation) could help maintain cognition and reduce expected cognitive decline in a woman diagnosed with Alzheimer’s disease.